Univariable | Multivariable | ||||
---|---|---|---|---|---|
Variables | analysis | analysis | |||
n | Estimate (SE) | p-value | Estimate (SE) | OR (95%CI) | |
Abstract word count | |||||
≤ 300 | 98 | 1 | |||
> 300 | 40 | 1.068(0.539) | 0.049 | 0.741(0.332) | 1.456(0.658-3.240) |
Abstract format | |||||
8-headings | 16 | 1 | |||
IMRAD | 77 | − 1.205(0.418) | 0.004 | − 0.049(0.418) | 0.951(0.420-2.153) |
Free format | 45 | − 1.539(0.445) | < 0.001 | − 0.152(0.415) | 0.858(0.378-1.939) |
Cochrane affiliation | |||||
Yes | 9 | 1.068(0.539) | 0.049 | 0.543(0.734) | 1.722(0.401-7.296) |
No | 129 | 1 | |||
Number of authors | |||||
≤ 6 | 102 | 1 | |||
> 6 | 36 | 0.600(0.303) | 0.049 | 0.725(0.341) | 1.098(1.012-1.194) |
Conflict of interest | |||||
≤ 20% | 59 | 1 | |||
> 20% | 61 | − 0.400(0.260) | 0.126 | ||
Funding source | |||||
Academic | 39 | 1.156(0.283) | < 0.001 | 1.247(0.428) | 3.630(1.788-7.542) |
Pharmaceutical | 40 | − 0.198(0.297) | 0.506 | ||
No funding/UNK | 59 | 0.302(0.478) | 0.528 | ||
PRISMA endorser journal | |||||
Yes | 10 | 1.562(0.448) | 0.002 | 2.016(0.698) | 4.370(1.785-10.98) |
No | 117 | 1 | |||
PRISMA-A statement | |||||
Review published before | 71 | − 0.421(0.371) | 0.119 | ||
Review published after | 68 | 1 | |||
Journal impact factor | |||||
≤ 3 | 74 | 1 | |||
> 3 | 43 | 0.331(0.373) | 0.014 | 0.331(0.373) | 1.392(0.669-2.912) |